A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma

Hum Gene Ther. 2000 May 1;11(7):1065-82. doi: 10.1089/10430340050015374.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Cancer Vaccines / therapeutic use*
  • Clinical Protocols
  • Humans
  • Immunotherapy / methods*
  • Melanoma / secondary
  • Melanoma / therapy*

Substances

  • Cancer Vaccines